CervoMed (CRVO) Misses Q2 EPS by 27c

CervoMed (NASDAQ: CRVO) reported Q2 EPS of ($0.27). Revenue for the quarter came in at $3.29 million.

For earnings history and earnings-related data on CervoMed (CRVO) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• YouTube in talks for NBA local streaming rights deal worth over $1B - SBJ
• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright